Long-Term Outcomes of Adalimumab Treatment in Conventional Treatment-Resistant Serpiginous Choroiditis.
Berru Yargı ÖzkoçakCigdem AltanBurcu Kemer-AtikAli Safa BalciBerna BasarirPublished in: Ocular immunology and inflammation (2024)
Our findings suggest a promising role for ADA in halting the progression of SC and have implications for improving outcomes. Despite the evidence in the literature at the level of case reports, ADA can be used effectively with close monitoring for potential risks.